Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on TAHMS. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102399194A reveals a surfactant-assisted neutral hydrogenation process for TAHMS, offering significant cost reduction and purity improvements for pharmaceutical intermediate manufacturing.
Patent CN115286584A reveals a novel synthesis route for 2,4,5-triamino-6-hydroxypyrimidine sulfate, offering significant cost reduction and waste minimization for API manufacturers.